Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of

Equity Securities

Our common stock is traded on the Nasdaq Global Select Market tier of

the Nasdaq Stock Market, or Nasdaq,

under the symbol HSIC.

On February 17, 2026, there were approximately 251 holders of record

of our common stock and the last reported

sales price was $77.21.

A substantially greater number of holders of our common

stock are “street name” or

beneficial holders, whose shares are held by banks, brokers and other financial

institutions.

Purchases of Equity Securities by the Issuer

Our share repurchase program, announced on March 3, 2003, originally

allowed us to repurchase up to two million

shares pre-stock splits (eight million shares post-stock splits) of our common

stock, which represented

approximately 2.3% of the shares outstanding at the commencement

of the program.

Subsequent additional

increases since 2003 that have aggregated to an additional $6.7 billion,

authorized by our Board, to the repurchase

program provide for a total of $6.8 billion (including $500 million authorized

on January 27, 2025 and an

additional $750 million authorized on September 8, 2025) of shares of our common

stock to be repurchased under

this program, with $780 million currently available for future share repurchases.

On May 19, 2025, we executed an accelerated share repurchase program

to repurchase a total of $250 million of

our outstanding common stock based on volume-weighted average

prices.

In May 2025 we received 3,122,832

shares at an estimated fair value of $224 million.

In July 2025, we received an additional 368,651 shares at an

estimated fair value of $26 million, representing the final amount of shares

to be received under this accelerated

share repurchase program.

As of December 27, 2025, we had repurchased approximately $6.0

billion of common stock (107,876,628) shares

under these initiatives,

with $780 million available for future common stock share repurchases.

The following table summarizes repurchases of our common stock

under our stock repurchase program during the

fiscal quarter ended December 27, 2025:

Total Number

Maximum Number

Total

of Shares

of Shares

Number

Average

Purchased as Part

that May Yet

of Shares

Price Paid

of Our Publicly

Be Purchased Under

Fiscal Month

Purchased (1)

Per Share

Announced Program

Our Program (2)

9/28/2025 through 11/1/2025

1,020,000

$

64.28

1,020,000

14,467,711

11/2/2025 through 11/29/2025

488,067

70.55

488,067

11,799,992

11/30/2025 through 12/27/2025

1,304,805

76.64

1,304,805

10,244,654

2,812,872

2,812,872

(1)

All repurchases were executed in the open market under our existing publicly announced authorized program.

(2)

The maximum number of shares that may yet be purchased under this program is determined at the end of each month based on the

closing price of our common stock at that time.

This table excludes shares withheld from employees to satisfy minimum tax

withholding requirements for equity-based transactions.

Dividend Policy

We have not declared any cash or stock dividends on our common stock during fiscal years 2025 or 2024.

We

currently do not anticipate declaring any cash or stock dividends on our common

stock in the foreseeable future.

We intend to retain earnings to finance the expansion of our business and for general corporate purposes, including

our share repurchase program.

Any declaration of dividends will be at the discretion of our Board and

will depend

upon the earnings, financial condition, capital requirements, level

of indebtedness, contractual restrictions with

respect to payment of dividends and other factors.

Index to Financial Statements

$50

$100

$150

$200

$250

December 2020

December 2021

December 2022

December 2023

December 2024

December 2025

Henry Schein, Inc.

Dow Jones US Health Care Index

NASDAQ Composite Index

Stock Performance Graph

The graph below compares the cumulative total stockholder return

on $100 invested, assuming the reinvestment of

all dividends, on December 26, 2020, the last trading day before the

beginning of our 2021 fiscal year, through the

end of our 2025 fiscal year with the cumulative total return on $100 invested

for the same period in the Dow Jones

U.S. Health Care Index and the Nasdaq Stock Market Composite Index.

COMPARISON OF 5-YEAR CUMULATIVE TOTAL

RETURN

ASSUMES $100 INVESTED ON DECEMBER 26, 2020

ASSUMES DIVIDENDS REINVESTED

December 26,

December 25,

December 31,

December 30,

December 28,

December 27,

2020

2021

2022

2023

2024

2025

Henry Schein, Inc.

$

100.00

$

113.81

$

121.30

$

114.96

$

106.92

$

115.57

Dow Jones U.S. Health

Care Index

100.00

124.30

119.60

121.86

126.18

144.40

NASDAQ Stock Market

Composite Index

100.00

123.04

82.97

120.01

158.80

191.20